Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - January 2013


Pharmaceutical Microbiology

30 Jan 2013 - 31 Jan 2013 - London, UK



Bookmark and Share


Book by 28th September and receive a £300 discount

Visit www.pharma-microbiology.com to claim your discount now!

Don’t miss SMi’s 2nd annual Pharmaceutical Microbiology conference that aims to provide an expert and highly accredited speaker line up including 13 pharma speakers who will focus on the latest developments and procedures used in the identification and prevention of contaminating agents, updates on new rules and regulations and the challenges facing the Pharmaceutical Microbiology industry. 

Reasons you should not miss this incredible event includes:

Discuss developments in tools, techniques and procedures used in identification and control of contaminants

Evaluate the handling of traditional drug and biologics & sterile product manufacturing 

Hear about design, construction and validation of sterile facilities and equipment

Engage with those currently working on producing the rapid microbial methods

Key Speakers include:

Oliver Chancel, Microbiologist, Sanofi-Aventis

Kim Bowers, Senior Scientist, Pfizer

Praful Bhusari, Associate Scientist, MedImmune

John Duguid, Principle Analytical Scientist, Genzyme

Scott Smith, Microbiology Team Leader, Sanofi-Aventis

Anne Warford, Associate Director, MedImmune

Amy McDaniel, Director, QC Microbiology, Pfizer

Stephen Rawling, Microbiology Team Leader, GlaxoSmithKline

Brendan Gilmore, Research Scientist, Queens University Belfast

Andrew Bartko, Senior Scientist, Battelle Research Institute

Hilary Chan, Quality Scientist IV, Pfizer  

Mark Thompson, Consultant, EPIC Consultancy & Training

Daniel Kockelkorn, Head of PKau Laboratory, Roche 

Emiliano Toso, Principle Scientist, Merck 

Gunther Meike, System Development Specialist, Charles River Laboratories

For more information contact Farhaana Rahman on +44 0 207 827 6186 or email frahman@smi-online.co.uk 



Further information
Scientific News
Head Injury Patients have Protein Clumps Associated with Alzheimer’s Disease
Scientists have revealed that protein clumps associated with Alzheimer's disease are also found in the brains of people who have had a head injury.
Exposure to Air Pollution 30 Years Ago Associated with Increased Risk of Death
Exposure to air pollution more than 30 years ago may still affect an individual's mortality risk today, according to new research from Imperial College London.
More Then 1 in 20 U.S. Children have Dizziness and Balance Problems
Researchers at NIH have found that girls have a higher prevalence of dizziness and balance problems compared to boys, 5.7 percent and 5.0 percent.
Biosensors on Demand
New strategy results in custom "designer proteins" for sensing a variety of molecules.
Low-Cost, Portable NQR Spectroscopy
A researcher at Case Western Reserve University is developing a low-cost, portable prototype designed to detect tainted medicines and food supplements that otherwise can make their way to consumers. The technology can authenticate good medicines and supplements.
Structure of Brain Plaques in Huntington's
Researchers at the University of Pittsburgh School of Medicine have shown that the core of the protein clumps found in the brains of people with Huntington's disease have a distinctive structure, a finding that could shed light on the molecular mechanisms underlying the neurodegenerative disorder.
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Unique Mechanism for a High-Risk Leukemia
Researchers uncovered the aberrant mechanism underlying a notoriously treatment-resistant acute lymphoblastic leukemia subtype; findings offer lessons for understanding all cancers.
Visualizing a Cancer Drug Target at Atomic Resolution
Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!